Bioinformatical analyses have recently validated the aberrant expression, prognostic values, and functions of FBXO43 in breast cancer, as well as the potential oncogenic roles of FBXO43 in gastric cancer and HCC [5,6,7,8]. This evidence concerns the gene FBXO43 and gastric cancer.